OLR1 and breast carcinoma: Pucci et al. [20] found that LOX-1 and its splice variant LOX-1Δ4 were highly expressed in breast cancer, and their expression patterns could be specifically regulated in different breast cancer phenotypes while affecting the proliferation rate and apoptosis of breast cancer cells, death induction, DNA repair process, and epigenetic status of cancer cells.